Interestingly, a BPN-14136 derivative was able to lower RBP4 and partially prevent high-fat diet induced obesity and hepatic steatosis in mice with adipose tissue-specific transgenic overexpression of human RBP4 described above (Cioffi et al., 2019). Here, RBP4 is linked to Hepatic steatosis.